AzTrials
AzTrials

OsteoporosisFKUINCT07677033

Functional Muscle-Bone Incongruity Index (FKUI): A Prospective Observational Study

An observational study of Osteoporosis and Musculoskeletal Health, run by Kanuni Sultan Suleyman Training and Research Hospital at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The Functional Muscle-Bone Incongruity Index (FKUI) is a novel approach developed to evaluate the relationship between muscle function and bone health. This prospective observational study aims to investigate the clinical applicability of FKUI, which combines handgrip strength, total hip bone mineral density (BMD)… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Osteoporosis, Musculoskeletal Health, Sarcopenia
How many people
200 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 May 2026to 1 May 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The study population will consist of adults aged 18 years and older attending the Physical Medicine and Rehabilitation outpatient clinic who are scheduled to undergo routine dual-energy X-ray absorptiometry (DXA) assessment as part of their clinical evaluation. Participants will be recruited consecutively from routine clinical practice. The study aims to evaluate the relationship between muscle function and bone health through the Functional Muscle-Bone Incongruity Index (FKUI), which incorporates handgrip strength, total hip bone mineral density, and lumbar-hip bone mineral density discordance.

Who may be able to join

  • Age 18 years or older
  • Attendance at the Physical Medicine and Rehabilitation outpatient clinic
  • Scheduled to undergo routine bone mineral density assessment by DXA as part of clinical evaluation
  • Ability to perform handgrip strength testing
  • Availability of lumbar spine and total hip bone mineral density measurements suitable for analysis
  • Ability and willingness to provide written informed consent

Who cannot join

  • Age younger than 18 years
  • Secondary causes of osteoporosis (e.g., hyperparathyroidism, Cushing syndrome, malignancy, or other conditions affecting bone metabolism)
  • History of metabolic bone disease
  • Major trauma or fracture within the previous 6 months
  • Upper extremity disorders that may significantly affect handgrip strength measurement (e.g., severe osteoarthritis, neurological disorders, major deformities)
  • DXA measurements that are technically inadequate or unsuitable for analysis
  • Refusal or inability to provide written informed consent

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Dilek Ün Oğuzhanasiltürk, MD contact

+90 5056367184

dilekunoguzhan@gmail.com

Turkey (Türkiye)1 site, 1 recruiting
  • Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Turkey

    Küçükçekmece, Istanbul, 34303

    Dilek Ün Oğuzhanasiltürk, MD, +905056367184, dilekunoguzhan@gmail.com

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: Functional Muscle-Bone Incongruity Index (FKUI): Combined Evaluation of Handgrip Strength, Total Hip Bone Mineral Density, and Lumbar-Hip Bone Mineral Density Discordance in Adults Undergoing DXA

The Functional Muscle-Bone Incongruity Index (FKUI) is a novel approach developed to evaluate the relationship between muscle function and bone health. This prospective observational study aims to investigate the clinical applicability of FKUI, which combines handgrip strength, total hip bone mineral density (BMD), and lumbar-hip BMD discordance. Approximately 200 adult participants undergoing routine DXA assessment will be enrolled. The study will examine whether the combined evaluation of muscle function and bone health parameters provides a more comprehensive assessment of musculoskeletal status than individual measures alone.

Read the detailed description

This is a prospective, observational, single-center study evaluating adults undergoing routine DXA assessment in a Physical Medicine and Rehabilitation outpatient clinic. The study will investigate the clinical applicability of the Functional Muscle-Bone Incongruity Index (FKUI), a composite approach based on handgrip strength, total hip bone mineral density, and lumbar-hip bone mineral density discordance. No treatment or interventional procedure will be administered as part of the study. Handgrip strength will be measured using a calibrated hand dynamometer, and DXA-derived bone mineral density values will be recorded from routine clinical assessments. The study aims to determine whether the combined evaluation of muscle function and bone health parameters may provide a more comprehensive assessment of musculoskeletal status.

Keywords
Functional Muscle-Bone Incongruity Index FKUI, FKUI, Bone Mineral Density, Hip-Spine Discordance, Handgrip Strength
Medical subject headings
Osteoporosis, Sarcopenia, Bone Diseases, Metabolic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07677033
Study groupRoleWhat they receive
Adults Undergoing Bone Mineral Density EvaluationAdult patients attending the Physical Medicine and Rehabilitation outpatient clinic and undergoing routine DXA assessment as part of clinical evaluation. Participants will undergo handgrip strength measurement and assessment of bone mineral density parameters. The Functional Muscle-Bone Incongruity Index (FKUI) will be evaluated using handgrip strength, total hip bone mineral density, and lumbar-hip bone mineral density discordance. No treatment or interventional procedure will be administered.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Functional Muscle-Bone Incongruity Index (FKUI)

    Assessment of the clinical applicability of the Functional Muscle-Bone Incongruity Index (FKUI), a composite index based on handgrip strength, total hip bone mineral density, and lumbar-hip bone mineral density discordance.

    Measured: Baseline (at study enrollment)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Jun 2026
  2. Study start1 May 2026
  3. Primary completion1 May 2027 (estimated)
  4. Study completion1 May 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07677033
Sponsor's protocol ID
FKUI
Other IDs
KSS-TRH-FKUI-2026
Acronym
FKUI
Status last verified
May 2026
First submitted
24 Jun 2026
Last updated
30 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: No plan has been established to share individual participant data. Participant confidentiality will be maintained in accordance with ethical and institutional requirements.

Questions about this trial

What is this clinical trial studying?

An observational study of Osteoporosis and Musculoskeletal Health, run by Kanuni Sultan Suleyman Training and Research Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 30 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Dilek Ün Oğuzhanasiltürk, MD (+90 5056367184, dilekunoguzhan@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Functional Muscle-Bone Incongruity Index (FKUI) (time frame: Baseline (at study enrollment)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in